Toll-like receptor 4/spleen tyrosine kinase complex in high glucose signal transduction of proximal tubular epithelial cells

Cellular Physiology and Biochemistry

Volumn 35, Issue 6, 2015, Pages 2309-2319

  Yang, Won Seok ^a   Kim, Joon Seok ^a   Han, Nam Jeong ^b   Lee, Mee Jeong ^c   Park, Su Kil ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c Dankook University   (South Korea)

Author keywords

High glucose; High mobility group box 1; MyD88; Spleen tyrosine kinase; Toll like receptor 4; Transforming growth factor 1

Indexed keywords

ACETYLCYSTEINE; GLUCOSE; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MULTIPROTEIN COMPLEX; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE SYK; RESATORVID; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SIGNAL PEPTIDE; TLR4 PROTEIN, HUMAN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; PHYSIOLOGY;

ACETYLCYSTEINE; CELLS, CULTURED; EPITHELIAL CELLS; GLUCOSE; GLYCYRRHIZIC ACID; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES, PROXIMAL; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84928156443     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000374034     Document Type: Article

References (24)

1. Sada K, Takano T, Yanagi S, Yamamura H: Structure and function of Syk protein-tyrosine kinase. J Biochem 2001;130:177-186.
2. Patterson H, Nibbs R, McInnes I, Siebert S: Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol 2014;176:1-10.
3. Yanagi S, Inatome R, Takano T, Yamamura H: Syk expression and novel function in a wide variety of tissues. Biochem Biophys Res Commun 2001;288:495-498.
4. Yang WS, Seo JW, Han NJ, Choi J, Lee KU, Ahn H, Lee SK, Park SK: High glucose-induced NF-κB activation occurs via tyrosine phosphorylation of IκBα in human glomerular endothelial cells: involvement of Syk tyrosine kinase. Am J Physiol Renal Physiol 2008;294:F1065-F1075.
5. Yang WS, Chang JW, Han NJ, Lee SK, Park SK: Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells. Exp Cell Res 2012;318:1867-1876.
6. Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009;388:621-625.
7. Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS: Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-kinase and Syk-mediated pathways. J Biol Chem 2004;279:10883-10891.
8. Chaudhary A, Fresquez TM, Naranjo MJ: Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells. Immunol Cell Biol 2007;85:249-256.
9. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, Witztum JL, Miller YI: Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res 2009;104:210-218.
10. Yu L, Wang L, Chen S: Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 2010;14:2592-2603.
11. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC: Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 2012;23:86-102.
12. Lin M, Yiu WH, Li RX, Wu HJ, Wong DW, Chan LY, Leung JC, Lai KN, Tang SC: The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int 2013;83:887-900.
13. Cha JJ, Hyun YY, Lee MH, Kim JE, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Han JY, Cha DR: Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 2013;154:2144-2155.
14. Kaur H, Chien A, Jialal I: Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy. Am J Physiol Renal Physiol 2012;303:F1145-F1150.
15. Zhang J, Billingsley ML, Kincaid RL, Siraganian RP: Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J Biol Chem 2000;275:35442-35447.
16. Garg A, Aggarwal BB: Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 2002;16:1053-1068.
17. Matsunaga N, Tsuchimori N, Matsumoto T, Ii M: TAK-242 (resatorvid), a small-molecule inhibitor of Tolllike receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 2011;79:34-41.
18. Choi SH, Harkewicz R, Lee JH, Boullier A, Almazan F, Li AC, Witztum JL, Bae YS, Miller YI: Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 2009;104:1355-1363.
19. Miller YI, Choi SH, Wiesner P, Bae YS: The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL. Br J Pharmacol 2012;167:990-999.
20. Van Crombruggen K, Jacob F, Zhang N, Bachert C: Damage-associated molecular patterns and their receptors in upper airway pathologies. Cell Mol Life Sci 2013;70:4307-4321.
21. Yanai H, Ban T, Taniguchi T: High-mobility group box family of proteins: ligand and sensor for innate immunity. Trends Immunol 2012;33:633-640.
22. Wang Y, Shan J, Yang W, Zheng H, Xue S: High mobility group box 1 (HMGB1) mediates high-glucoseinduced calcification in vascular smooth muscle cells of saphenous veins. Inflammation 2013;36:1592-1604.
23. Dasu MR, Devaraj S, Park S, Jialal I: Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010;33:861-868.
24. Tang D, Shi Y, Kang R, Li T, Xiao W, Wang H, Xiao X: Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007;81:741-747.